Home > Result Summaries: Compounds > GSK2018682 > Result Summary for 114919

Result Summary for 114919

Result Summary

Protocol ID:	114919
Clinical Study ID:	P1A114919
Official Title:	An open-label, randomised, crossover study to assess the relative bioavailability of different 2mg formulations of GSK2018682(S1P1 agonist) in healthy volunteers
Phase:	phase 1
Study Indications or Diseases:	Multiple Sclerosis, Relapsing-Remitting
Generic Name:	GSK2018682
Trade/Product Name:	Not applicable
Approved Drug Label:	http://www.gsk.com/products.html
Results Summary:	Click here to download result summary.
Citations:	GlaxoSmithKline Document Number JH2009/00002/01. GSK2018682 Investigator's Brochure. Bronnum-Hansen H, Stenager E, Hansen T, and N Koch-Henriksen. Survival and mortality rates among Danes with MS, Int MS J 2006; 13: 66-71. Confavreuax C, Vukusic S, Moreau T and P Adeleine. Relapses and progression of disability in MS N Engl J Med 2000; 343:1430-8. Chun J, Goetzl EJ, Hla T, Igarashi Y, Lynch KR, Moolenaar W et al, International union of pharmacology. XXXIV. Lysophospholipid receptor nomenclature. Pharmacol Rev 2002; 54 : 265-269. Compston A and Coles A, Multiple Sclerosis. Lancet 2008; 372: 1502-17.